News

Public Broadcasting Service (PBS)22h
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
Trials for new HIV prevention drug showed 99.9% of participants remained negative
The U.S. Food and Drug Administration has approved a new HIV prevention medication that's been found to be highly effective.
FDA approves twice-a-year shot to prevent HIV
Summer break brings some new concerns for parents, the medical workers helping the nation's aging homeless population, a ...
Here’s what everyone should know about this new HIV prevention shot
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...
Metro Weekly39m
FDA Approves PrEP Drug Requiring Only Two Injections Per Year
Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...
The Financial Express9h
US FDA approves twice-a-year HIV shot that could end daily pills
A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn ...
NIH office to phase out HIV guidelines by next year
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
FDA approves new HIV prevention drug
JACKSON, Miss. (WLBT) -A new breakthrough drug for HIV Prevention has been approved by the FDA. The drug is called “Yeztugo” ...
FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection
He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...
Daily Jang16h
FDA approves first twice-a-year and cost-effective HIV prevention shot
The Food and Drug Administration approved a new vaccine to prevent HIV infection, lenacapavir, a long-acting injection, which ...
HealthDay on MSN23h
FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk
The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as ...
KESQ20h
FDA approves twice-yearly HIV prevention shot amid questions over cost, access
The U.S. Food and Drug Administration has approved a groundbreaking HIV prevention shot that only needs to be taken twice a year. Medical experts are calling it one of the most significant ...